{
    "Trade/Device Name(s)": [
        "MEDTOX\u00ae OXYCODONE",
        "MEDTOX\u00ae OXYCODONE Test System",
        "MEDTOX \u211a OXYCODONE test system"
    ],
    "Submitter Information": "MedTox Diagnostics, Inc.",
    "510(k) Number": "K060351",
    "Predicate Device Reference 510(k) Number(s)": [
        "K040411"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG"
    ],
    "Summary Letter Date": "February 10, 2006",
    "Summary Letter Received Date": "February 13, 2006",
    "Submission Date": "February 10, 2006",
    "Regulation Number(s)": [
        "21CFR862.3650"
    ],
    "Regulation Name(s)": [
        "Opiate test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Oxycodone"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic test strip",
        "Competitive immunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Test System",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for MEDTOX\u00ae OXYCODONE immunochromatographic assay for rapid, qualitative detection of oxycodone in urine",
    "Indications for Use Summary": "For rapid, qualitative detection of oxycodone in human urine for prescription point-of-care, physician offices, laboratories, workplace, criminal justice, and drug rehabilitation settings; provides only a preliminary result, confirmation by GC/MS recommended",
    "fda_folder": "Toxicology"
}